Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report, BMC Neurology, October 2016, Springer Science + Business Media,
DOI: 10.1186/s12883-016-0720-2.
You can read the full text:
Contributors
The following have contributed to this page
